View Clinical Trial (Medical Research Study)
Multicomponent Cognitive Behavioral Therapy(CBT) for Posttraumatic Stress Disorder (PTSD) and Substance Abuse - NCT01029197-27516(Clinical Trial 446758)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Chapel Hill |
|
State:
|
|
NC |
| Zip Code: |
|
27516 |
| Conditions: |
|
Posttraumatic Stress Disorder - Substance Abuse |
| Purpose: |
|
Purpose: To conduct a pilot study of a cognitive-behavioral treatment (CBT) for PTSD and
substance abuse among persons with serious mental illness (SMI) treated in a community
setting.
Participants: Participants will be 50 volunteer adult individuals with PTSD and substance
use disorders (SUD), and SMI who are receiving services at the Freedom House Recovery
Center, served through the Orange Person Chatham (OPC) Area Program.
Procedures (methods): Participants will be randomly assigned to one of two conditions: 1)
the CBT intervention plus treatment as usual; or, 2) treatment as usual.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Must be at least 18 years of age
- Currently receiving services at Freedom House
- Meet DSM-IV criteria for PTSD
- Meet criteria for Substance Use Disorder
- Able to understand and provide informed consent
Exclusion Criteria:
• Psychiatric hospitalization or suicide attempt in the past two months |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
July 2, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|